Gene expression analysis reveals a different transcriptomic landscape in female and male breast cancer

Breast Cancer Research and Treatment

Volumn 127, Issue 3, 2011, Pages 601-610

  Callari, Maurizio ^a   Cappelletti, Vera ^a   De Cecco, Loris ^a,b   Musella, Valeria ^a   Miodini, Patrizia ^a   Veneroni, Silvia ^a   Gariboldi, Manuela ^a,b   Pierotti, Marco Alessandro ^a   Daidone, Maria Grazia ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

Author keywords

Breast cancer; Gender differences; Gene expression profile; Male breast cancer; Pathway analysis

Indexed keywords

ANDROGEN RECEPTOR; BETA TUBULIN; CYTOCHROME C; EPIDERMAL GROWTH FACTOR RECEPTOR 2; INITIATION FACTOR; MICROTUBULE ASSOCIATED PROTEIN; PEROXIREDOXIN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RIBOSOME PROTEIN; STEROID RECEPTOR;

ABCC2 GENE; ABCC5 GENE; ADAMTS GENE; ADULT; AGED; ARF GENE; ARTICLE; BREAST CANCER; CCL25 GENE; CD3 GENE; CELL GROWTH; CELL MOTILITY; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CXCL GENE; CXCL10 GENE; CYTOSKELETON; DOWN REGULATION; ENERGY METABOLISM; ERBB2 GENE; EXTRACELLULAR MATRIX; FEMALE; FGFR2 GENE; FN1 GENE; GENE AMPLIFICATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; GLUTATHIONE METABOLISM; HUMAN; IL23A GENE; LAMC1 GENE; LCK GENE; MALE; MALE BREAST; MEMBRANE TRANSPORT; MET GENE; MHC II GENE; MMP11 GENE; MMP7 GENE; ONCOGENE; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; RNA ISOLATION; SERPIN GENE; SEX DIFFERENCE; SLC16A3 GENE; SLC2A1 GENE; SLC2A3 GENE; TIMP3 GENE; TNC GENE; TRANSLATION REGULATION; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS, MALE; CHEMOKINES; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, BRCA1; GENES, BRCA2; HUMANS; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; POLYMERASE CHAIN REACTION; RECEPTOR, ERBB-2; RECEPTORS, ANDROGEN; RECEPTORS, PROGESTERONE; RHO GTP-BINDING PROTEINS; SEX FACTORS;

EID: 79958281904     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-1015-8     Document Type: Article

References (54)

1. KB Contractor K Kaur GS Rodrigues DM Kulkarni H Singhal 2008 Male breast cancer: is the scenario changing World J Surg Oncol 6 58 18558006 10.1186/1477-7819-6-58 (Pubitemid 351940521)
2. Z Nahleh S Girnius 2006 Male breast cancer: a gender issue Nat Clin Pract Oncol 3 428 437 16894388 10.1038/ncponc0564 (Pubitemid 44203815)
3. PC Willsher IH Leach IO Ellis JB Bourke RW Blamey JF Robertson 1997 A comparison outcome of male breast cancer with female breast cancer Am J Surg 173 185 188 9124623 10.1016/S0002-9610(97)89592-X 1:STN:280:DyaK2s3ks1Ggug%3D%3D (Pubitemid 27163845)
4. PE Goss C Reid M Pintilie R Lim N Miller 1999 Male breast carcinoma: a review of 229 patients who presented to the Princess Margaret Hospital during 40 years: 1955-1996 Cancer 85 629 639 10091736 10.1002/(SICI)1097-0142(19990201) 85:3<629::AID-CNCR13>3.0.CO;2-V 1:STN:280:DyaK1M7ptVWmtQ%3D%3D (Pubitemid 29075284)
5. MM Munoz de Toro MV Maffini L Kass EH Luque 1998 Proliferative activity and steroid hormone receptor status in male breast carcinoma J Steroid Biochem Mol Biol 67 333 339 9883990 10.1016/S0960-0760(98)00124-1 1:STN:280: DyaK1M%2FpvVCmuw%3D%3D (Pubitemid 28559231)
6. G Curigliano M Colleoni G Renne G Mazzarol R Gennari G Peruzzotti E de Braud C Robertson E Maiorano P Veronesi F Nole M Mandala G Ferretti G Viale A Goldhirsch 2002 Recognizing features that are dissimilar in male and female breast cancer: expression of p21Waf1 and p27Kip1 using an immunohistochemical assay Ann Oncol 13 895 902 12123335 10.1093/annonc/mdf166 1:STN:280: DC%2BD38znslKksQ%3D%3D (Pubitemid 34752685)
7. KJ Bloom H Govil P Gattuso V Reddy D Francescatti 2001 Status of HER-2 in male and female breast carcinoma Am J Surg 182 389 392 11720677 10.1016/S0002-9610(01)00733-4 1:CAS:528:DC%2BD3MXosFKqtb0%3D (Pubitemid 33079093)
8. K Weber-Chappuis S Bieri-Burger J Hurlimann 1996 Comparison of prognostic markers detected by immunohistochemistry in male and female breast carcinomas Eur J Cancer 32A 1686 1692 8983275 10.1016/0959-8049(96)00154-2 1:STN:280:DyaK2s7gsFKgtA%3D%3D (Pubitemid 26306878)
9. C Sotiriou L Pusztai 2009 Gene-expression signatures in breast cancer N Engl J Med 360 790 800 19228622 10.1056/NEJMra0801289 1:CAS:528: DC%2BD1MXitFWqs70%3D
10. M Fassan R Baffa JP Palazzo J Lloyd M Crosariol CG Liu S Volinia H Alder M Rugge CM Croce A Rosenberg 2009 MicroRNA expression profiling of male breast cancer Breast Cancer Res 11 R58 19664288 10.1186/bcr2348
11. E Ronchi G Granata M Brivio D Coradini P Miodini G Di Fronzo 1986 A double-labeling assay for simultaneous estimation and characterization of estrogen and progesterone receptors using radioiodinated estradiol and tritiated Org 2058 Tumori 72 251 257 3739005 1:CAS:528:DyaL28XlsVKgtLo%3D (Pubitemid 17190690)
12. V Cappelletti M Gariboldi L De Cecco S Toffanin JF Reid L Lusa E Bajetta L Celio M Greco A Fabbri MA Pierotti MG Daidone 2008 Patterns and changes in gene expression following neo-adjuvant anti-estrogen treatment in estrogen receptor-positive breast cancer Endocr Relat Cancer 15 439 449 18508997 10.1677/ERC-07-0274 1:CAS:528:DC%2BD1cXosVGjsrk%3D (Pubitemid 351880833)
13. VG Tusher R Tibshirani G Chu 2001 Significance analysis of microarrays applied to the ionizing radiation response Proc Natl Acad Sci USA 98 5116 5121 11309499 10.1073/pnas.091062498 1:CAS:528:DC%2BD3MXjt1Ons7w%3D (Pubitemid 32397092)
14. A Alexa J Rahnenfuhrer T Lengauer 2006 Improved scoring of functional groups from gene expression data by decorrelating GO graph structure Bioinformatics 22 1600 1607 16606683 10.1093/bioinformatics/btl140 1:CAS:528:DC%2BD28XmsVentro%3D (Pubitemid 43985293)
15. O Warburg 1956 On respiratory impairment in cancer cells Science 124 269 270 13351639 1:STN:280:DyaG287gsVeksA%3D%3D
16. MG Vander Heiden LC Cantley CB Thompson 2009 Understanding the Warburg effect: the metabolic requirements of cell proliferation Science 324 1029 1033 19460998 10.1126/science.1160809 1:CAS:528:DC%2BD1MXmtVKlsbg%3D
17. L Putignani S Raffa R Pescosolido L Aimati F Signore MR Torrisi P Grammatico 2008 Alteration of expression levels of the oxidative phosphorylation system (OXPHOS) in breast cancer cell mitochondria Breast Cancer Res Treat 110 439 452 17899367 10.1007/s10549-007-9738-x 1:CAS:528:DC%2BD1cXosVOgt7g%3D (Pubitemid 351962585)
18. SR Sennoune D Luo R Martinez-Zaguilan 2004 Plasmalemmal vacuolar-type H+-ATPase in cancer biology Cell Biochem Biophys 40 185 206 15054222 10.1385/CBB:40:2:185 1:CAS:528:DC%2BD2cXjtlKmu74%3D (Pubitemid 41270787)
19. CA Neumann Q Fang 2007 Are peroxiredoxins tumor suppressors? Curr Opin Pharmacol 7 375 380 17616437 10.1016/j.coph.2007.04.007 1:CAS:528: DC%2BD2sXpsFKqsrY%3D (Pubitemid 47289263)
20. JJ Mieyal MM Gallogly S Qanungo EA Sabens MD Shelton 2008 Molecular mechanisms and clinical implications of reversible protein S-glutathionylation Antioxid Redox Signal 10 1941 1988 18774901 10.1089/ars.2008.2089 1:CAS:528:DC%2BD1cXhtVymsbrJ
21. JR Graff BW Konicek JH Carter EG Marcusson 2008 Targeting the eukaryotic translation initiation factor 4E for cancer therapy Cancer Res 68 631 634 18245460 10.1158/0008-5472.CAN-07-5635 1:CAS:528:DC%2BD1cXhtlyhurg%3D (Pubitemid 351206735)
22. Y Mamane E Petroulakis O LeBacquer N Sonenberg 2006 mTOR, translation initiation and cancer Oncogene 25 6416 6422 17041626 10.1038/sj.onc.1209888 1:CAS:528:DC%2BD28XhtVOlsrrP (Pubitemid 44582285)
23. M Caraglia A Budillon G Vitale G Lupoli P Tagliaferri A Abbruzzese 2000 Modulation of molecular mechanisms involved in protein synthesis machinery as a new tool for the control of cell proliferation Eur J Biochem 267 3919 3936 10866791 10.1046/j.1432-1327.2000.01465.x 1:CAS:528:DC%2BD3cXkvFCmu7c%3D (Pubitemid 30436083)
24. X Perez-Martinez S Funes Y Camacho-Villasana S Marjavaara F Tavares-Carreon M Shingu-Vazquez 2008 Protein synthesis and assembly in mitochondrial disorders Curr Top Med Chem 8 1335 1350 18991722 10.2174/156802608786141124 1:CAS:528:DC%2BD1cXhsFWgt7zF
25. JT Hunt 2009 Discovery of ixabepilone Mol Cancer Ther 8 275 281 19174552 10.1158/1535-7163.MCT-08-0999 1:CAS:528:DC%2BD1MXhvFams7k%3D
26. T Cigler LT Vahdat 2010 Eribulin mesylate for the treatment of breast cancer Expert Opin Pharmacother 11 1587 1593 20450446 10.1517/14656566.2010. 486790 1:CAS:528:DC%2BC3cXmt12lsbY%3D
27. S Etienne-Manneville A Hall 2002 Rho GTPases in cell biology Nature 420 629 635 12478284 10.1038/nature01148 1:CAS:528:DC%2BD38XpsVSitbw%3D (Pubitemid 36764489)
28. FM Vega AJ Ridley 2008 Rho GTPases in cancer cell biology FEBS Lett 582 2093 2101 18460342 10.1016/j.febslet.2008.04.039 1:CAS:528:DC%2BD1cXms1WgtLk%3D
29. J Howlin J Rosenkvist T Andersson 2008 TNK2 preserves epidermal growth factor receptor expression on the cell surface and enhances migration and invasion of human breast cancer cells Breast Cancer Res 10 R36 18435854 10.1186/bcr2087
30. WJ Chia BL Tang 2009 Emerging roles for Rab family GTPases in human cancer Biochim Biophys Acta 1795 110 116 19425190 1:CAS:528:DC%2BD1MXjvVSqu7c%3D
31. S Hashimoto Y Onodera A Hashimoto M Tanaka M Hamaguchi A Yamada H Sabe 2004 Requirement for Arf6 in breast cancer invasive activities Proc Natl Acad Sci USA 101 6647 6652 15087504 10.1073/pnas.0401753101 1:CAS:528: DC%2BD2cXjvVyiu7k%3D (Pubitemid 38586028)
32. WM Rensen R Mangiacasale M Ciciarello P Lavia 2008 The GTPase Ran: regulation of cell life and potential roles in cell transformation Front Biosci 13 4097 4121 18508502 10.2741/2996 1:CAS:528:DC%2BD1cXnsVKqu7s%3D (Pubitemid 351611596)
33. A Kohrmann U Kammerer M Kapp J Dietl J Anacker 2009 Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: new findings and review of the literature BMC Cancer 9 188 19531263 10.1186/1471-2407-9-188
34. J Helleman MP Jansen K Ruigrok-Ritstier IL van Staveren MP Look ME Meijer-van Gelder AM Sieuwerts JG Klijn S Sleijfer JA Foekens EM Berns 2008 Association of an extracellular matrix gene cluster with breast cancer prognosis and endocrine therapy response Clin Cancer Res 14 5555 5564 18765548 10.1158/1078-0432.CCR-08-0555 1:CAS:528:DC%2BD1cXhtVKmsbbK
35. G Finak N Bertos F Pepin S Sadekova M Souleimanova H Zhao H Chen G Omeroglu S Meterissian A Omeroglu M Hallett M Park 2008 Stromal gene expression predicts clinical outcome in breast cancer Nat Med 14 518 527 18438415 10.1038/nm1764 1:CAS:528:DC%2BD1cXlsFCms7w%3D (Pubitemid 351655218)
36. FT Bosman I Stamenkovic 2003 Functional structure and composition of the extracellular matrix J Pathol 200 423 428 12845610 10.1002/path.1437 1:CAS:528:DC%2BD3sXnvF2ns7o%3D (Pubitemid 36818243)
37. JA Coronella-Wood EM Hersh 2003 Naturally occurring B-cell responses to breast cancer Cancer Immunol Immunother 52 715 738 12920480 10.1007/s00262-003- 0409-4 (Pubitemid 37491701)
38. KE de Visser A Eichten LM Coussens 2006 Paradoxical roles of the immune system during cancer development Nat Rev Cancer 6 24 37 16397525 10.1038/nrc1782 (Pubitemid 43053650)
39. M Schmidt D Bohm C von Torne E Steiner A Puhl H Pilch HA Lehr JG Hengstler H Kolbl M Gehrmann 2008 The humoral immune system has a key prognostic impact in node-negative breast cancer Cancer Res 68 5405 5413 18593943 10.1158/0008-5472.CAN-07-5206 1:CAS:528:DC%2BD1cXnvFyjtb4%3D
40. A Rody U Holtrich L Pusztai C Liedtke R Gaetje E Ruckhaeberle C Solbach L Hanker A Ahr D Metzler K Engels T Karn M Kaufmann 2009 T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers Breast Cancer Res 11 R15 19272155 10.1186/bcr2234
41. V Materna A Stege P Surowiak A Priebsch H Lage 2006 RNA interference-triggered reversal of ABCC2-dependent cisplatin resistance in human cancer cells Biochem Biophys Res Commun 348 153 157 16876126 10.1016/j.bbrc.2006.07.022 1:CAS:528:DC%2BD28Xot1Wqtbo%3D (Pubitemid 44163494)
42. DA Weaver EL Crawford KA Warner F Elkhairi SA Khuder JC Willey 2005 ABCC5, ERCC2, XPA and XRCC1 transcript abundance levels correlate with cisplatin chemoresistance in non-small cell lung cancer cell lines Mol Cancer 4 18 15882455 10.1186/1476-4598-4-18 (Pubitemid 41460841)
43. L He K Vasiliou DW Nebert 2009 Analysis and update of the human solute carrier (SLC) gene superfamily Hum Genomics 3 195 206 19164095 1:CAS:528:DC%2BC3cXpt1yrsrg%3D
44. S Britsch 2007 The neuregulin-I/ErbB signaling system in development and disease Adv Anat Embryol Cell Biol 190 1 65 17432114 10.1007/978-3-540-37107-6-1
45. E Lengyel D Prechtel JH Resau K Gauger A Welk K Lindemann G Salanti T Richter B Knudsen GF Vande Woude N Harbeck 2005 C-Met overexpression in node-positive breast cancer identifies patients with poor clinical outcome independent of Her2/neu Int J Cancer 113 678 682 15455388 10.1002/ijc.20598 1:CAS:528:DC%2BD2MXms1Km (Pubitemid 40038747)
46. 2- and COOH-terminal interaction of the androgen receptor Biochem Biophys Res Commun 373 373 377 18565325 10.1016/j.bbrc.2008.06.024 1:CAS:528:DC%2BD1cXoslGmtbY%3D
47. HY Kang S Yeh N Fujimoto C Chang 1999 Cloning and characterization of human prostate coactivator ARA54, a novel protein that associates with the androgen receptor J Biol Chem 274 8570 8576 10085091 10.1074/jbc.274.13.8570 1:CAS:528:DyaK1MXitFyrsLY%3D (Pubitemid 29164648)
48. SR Lee SM Ramos A Ko D Masiello KD Swanson ML Lu SP Balk 2002 AR and ER interaction with a p21-activated kinase (PAK6) Mol Endocrinol 16 85 99 11773441 10.1210/me.16.1.85 1:CAS:528:DC%2BD38XhvVCiug%3D%3D (Pubitemid 34044500)
49. N Schrantz J da Silva Correia B Fowler Q Ge Z Sun GM Bokoch 2004 Mechanism of p21-activated kinase 6-mediated inhibition of androgen receptor signaling J Biol Chem 279 1922 1931 14573606 10.1074/jbc.M311145200 1:CAS:528:DC%2BD2cXisF2kug%3D%3D (Pubitemid 38084463)
50. C Rudlowski N Friedrichs A Faridi L Fuzesi R Moll G Bastert W Rath R Buttner 2004 Her-2/neu gene amplification and protein expression in primary male breast cancer Breast Cancer Res Treat 84 215 223 15026619 10.1023/B:BREA. 0000019953.92921.7e 1:CAS:528:DC%2BD2cXitFWrurw%3D (Pubitemid 38445371)
51. RR Fonseca AR Tomas S Andre J Soares 2006 Evaluation of ERBB2 gene status and chromosome 17 anomalies in male breast cancer Am J Surg Pathol 30 1292 1298 17001161 10.1097/01.pas.0000213354.72638.bd (Pubitemid 44454709)
52. M Chanrion V Negre H Fontaine N Salvetat F Bibeau G Mac Grogan L Mauriac D Katsaros F Molina C Theillet JM Darbon 2008 A gene expression signature that can predict the recurrence of tamoxifen-treated primary breast cancer Clin Cancer Res 14 1744 1752 18347175 10.1158/1078-0432.CCR-07-1833 1:CAS:528:DC%2BD1cXjtlejtbs%3D (Pubitemid 351469459)
53. JS Ross EA Slodkowska WF Symmans L Pusztai PM Ravdin GN Hortobagyi 2009 The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine Oncologist 14 320 368 19346299 10.1634/theoncologist. 2008-0230 1:CAS:528:DC%2BD1MXlvFOhtLw%3D
54. LA Korde JA Zujewski L Kamin S Giordano S Domchek WF Anderson JMS Bartlett K Gelmon Z Nahleh J Bergh B Cutuli G Pruneri W McCaskill-Stevens J Gralow G Hortobagyi F Cardoso 2010 Multidisciplinary meeting on male breast cancer: summary and research recommendations J Clin Oncol 28 2114 2122 20308661 10.1200/JCO.2009.25.5729